PT  - JOURNAL ARTICLE
AU  - Bonnet, Florian
AU  - Camarda, Carlo Giovanni
TI  - Estimating Subnational Excess Mortality in Times of Pandemic. An application to French <em>départements</em> in 2020
AID  - 10.1101/2022.12.12.22283346
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.12.12.22283346
4099  - http://medrxiv.org/content/early/2022/12/12/2022.12.12.22283346.short
4100  - http://medrxiv.org/content/early/2022/12/12/2022.12.12.22283346.full
AB  - The Covid-19 pandemic did not affect sub-national regions in a uniform way. Knowledge of the impact of the pandemic on mortality at the local level is therefore an important issue for better assessing its burden. Vital statistics are now available for an increasing number of countries for 2020 and 2021, and allow the calculation of sub-national excess mortality. However, this calculation faces two important methodological challenges: (1) it requires appropriate mortality projection models; (2) small populations implies important uncertainty in the estimates, commonly neglected. We address both issues by adopting a method to forecast mortality at sub-national level and by incorporating uncertainty in the computation of mortality measures. We illustrate our approach to French départements (NUTS 3, 95 geographical units) and produce estimates for 2020 and both sexes. Nonetheless, the proposed approach is so flexibility to allow estimation of excess mortality during Covid-19 in most demographic scenarios as well as for past pandemics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used ONLY openly available human data available at : https://osf.io/zt2c8/?view_only=16ff2a7384c04659bdc39c6a223f2403I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at : https://osf.io/zt2c8/?view_only=16ff2a7384c04659bdc39c6a223f2403 https://osf.io/zt2c8/?view_only=16ff2a7384c04659bdc39c6a223f2403